Close Menu

technology commercialization

Former Introgen Therapeutics CEO David Nance founded the non-profit to promote tech commercialization and economic development by linking in-state academic researchers, angel and VC investors, entrepreneurs, and incubators.

William Luster, Charles Hamner, Tamika Stubbs, Pinku Mukherjee, Leanna Read, Lusia Guthrie

Tech Transfer Tidbits

Premium

Battelle Ventures, MIT, Hepragen, Wayne State University, Defyrus, UK Ministry of Defence, Columbia U, Intelligent Bio-Systems, Kauffman Foundation

Pages

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.